ClinicalTrials.Veeva

Menu

Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections

Coloplast logo

Coloplast

Status

Completed

Conditions

Urinary Tract Infections

Treatments

Device: SpeediCath
Device: Conveen Uncoated

Study type

Interventional

Funder types

Industry

Identifiers

NCT00318591
DK046CC

Details and patient eligibility

About

The purpose of this study is to investigate the frequency of urinary tract infections with symptoms in spinal cord injured patients requiring intermittent catheterization for emptying the bladder. Patients will use either a coated catheter or an uncoated catheter with gel.

Full description

Introduction:

Spinal cord injured (SCI) constitutes a large group of patients suffering from neurogenic bladder dysfunction, which is often managed by intermittent catheterization (IC). Intermittent catheterization is accepted as a safe and effective method for maintaining bladder and renal health in individuals with neurogenic bladder dysfunction. However, IC several times a day places an individual at risk for urethral trauma, hematuria, and particularly symptomatic urinary tract infections (UTI).

Attempts to control UTI with prophylactic antibiotics or sterile technique have not been overly successful but more recent advances in catheter technology, such as the hydrophilic-coated catheter, offer potential benefit. The hydrophilic-coated catheter has a slippery, pre-lubricated surface (along the entire length of the catheter) when soaked in water, allowing smooth insertion without the need for additional water soluble lubricant. Two proposed advantages over uncoated catheters are 1) reduced incidence of symptomatic UTI, and 2) reduction of urethral irritation or urethral trauma, and lowered risk of urethral strictures. Currently, while there are trends in favour of hydrophilic-coated catheters with respect to UTI overall evidence remains inadequate for clinical decision-making for choice of catheter type. Randomised trials to date have been limited by short follow up, heterogeneity, attrition, imprecise outcome measures, and varying definitions of UTI5. Conclusions of the Cochrane group in 20076 were echoed in a recent comprehensive re-view of all studies on hydrophilic-coated catheters - there is modest evidence favouring hydrophilic-coated catheter in reduction of UTI, but further robust research is required.

Enrollment

219 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Traumatic spinal cord injury within 3 months prior to inclusion
  • Neurogenic bladder dysfunction requiring intermittent catheterization at least 3 times daily

Exclusion criteria

  • Has symptoms of UTI at inclusion
  • Treated with prophylactic antibiotics to prevent UTIs
  • Has a history of unresolved bladder-ureteral reflux and/or stones in the urinary tract
  • Has used intermittent catheterization for more than 10 days prior to inclusion

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

219 participants in 2 patient groups

SpeediCath
Experimental group
Description:
hydrophilic-coated intermittent catheter
Treatment:
Device: SpeediCath
Conveen Uncoated
Experimental group
Description:
uncoated urinary intermittent catheter
Treatment:
Device: Conveen Uncoated

Trial contacts and locations

16

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems